✦ LIBER ✦

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group

✍ Scribed by Charlotte Levin Tykjær Jørgensen,Christina Bjerre,Bent Ejlertsen…

Book ID: 126371199
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 624 KB
Volume: 14
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-14-360

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P91 Gemcitabine, epirubicin, and docetax

P91 Gemcitabine, epirubicin, and docetaxel (GED) asneoadjuvant therapy. Updated results from a multicenter phase II trial in locally advanced breast cancer

✍ D. Yardley; P. Whitworth; F. Greco; L. Dunbar; H. Burris; M. White; M. Melodie; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 160 KB

648 - CAF vs CMF both with tamoxlfen in

648 - CAF vs CMF both with tamoxlfen in postmenopausal patients with advanced breast cancer — A randomized study with more than 10 years follow-up from the Danish breast cancer cooperative group

✍ M. Andersson; E.L. Madsen; M. Overgaard; P. Dombernowsky; H.T. Moundsen 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 267 KB

The potential risk of neoadjuvant chemot

The potential risk of neoadjuvant chemotherapy in breast cancer patients—results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)

✍ Susanne Taucher; Guenther G. Steger; Raimund Jakesz; Christoph Tausch; Viktor We 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 252 KB

Exemestane versus anastrozole as front-l

Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer : Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial

✍ Antonio Llombart-Cussac; Amparo Ruiz; Antonio Antón; Agustí Barnadas; Silvia Ant 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

Using Response to Primary Chemotherapy t

Using Response to Primary Chemotherapy to Select Postoperative Therapy: Long-Term Results from a Prospective Phase II Trial in Locally Advanced Primary Breast Cancer

✍ Ana Maria Gonzalez-Angulo; Ronald Walters; Kristine Broglio; Debbie K. Frye; Eri 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB

Gemcitabine, Epirubicin, and Paclitaxel

Gemcitabine, Epirubicin, and Paclitaxel Versus Fluorouracil, Epirubicin, and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: A Central European Cooperative Oncology Group International, Multicenter, Prospective, Randomized Phase III Trial

✍ Seidman, A.D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB